ArticleInternational journal of obesity (2005)2026
Metabolic bariatric surgery pays off: a longitudinal analysis of weight loss and HbA1c changes in real-world patients data in the West of Scotland.
Article in International journal of obesity (2005), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleThe long-term trajectories of weight loss and glycemic outcomes for patients who undergo bariatric surgery remain underexplored, particularly when comparing individuals who undergo surgery to those who are eligible but do not proceed after referral.
methodsThis retrospective cohort study examined 411 patients with type 2 diabetes and obesity who were referred for consideration of metabolic bariatric surgery (MBS) at University Hospital Ayr, Ayrshire & Arran, between January 2009 and December 2020. The primary outcomes were change in percentage total weight loss (%TWL) and Glycosylated Hemoglobin (HbA1c) from baseline to five years.
resultsOf the 411 patients included, 225 (54.7%) did not undergo bariatric surgery. There were no significant differences between the surgery and non-surgery groups with respect to age, BMI or sex. 260 (63%) of the patients were female, the mean age of patients was 48.3 years (SD = 8.5), and the mean BMI was 47.4 kg/m² (SD = 7.9). At five years, patients who underwent surgery maintained a 22.0% TWL reduction compared to 8.6% in the non-surgery group (p < 0.001). HbA1c decreased by 1.0% (95% CI: -1.31, -0.70) in the surgery group but increased by 0.4% (95% CI: 0.09, 0.71) in the non-surgery group. Adjusted mixed-effects modelling showed the annual HbA1c level decreased by 0.13% (95% CI: -0.18, -0.07; p < 0.001) in the surgery group, compared to an increase of 0.11% (95% CI: 0.05, 0.17; p < 0.001) in the non-surgery group. %TWL decreased by 1.31% per year (95% CI: -1.73, -0.88; p < 0.001) in the surgery group, while the non-surgery group experienced an increase of 1.11% (95% CI: 0.66, 1.55; p < 0.001).
conclusionPatients eligible for MBS who proceed with surgery achieve superior weight loss and glycaemic control compared to those who decide not to proceed with surgery. Opting out of surgery may have significant health implications, highlighting the need for alternative interventions such as intensive lifestyle modification, pharmacotherapy, and diabetes education programs for those unable or unwilling to undergo MBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.